Product Feature Type Start End Strand Length AA Length is TF
Rv2160A CDS 2421643 2422278 - 636 211 FALSE

Rv2160A () is predicted to be co-regulated in modules with residual and with residual .

This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , and for and and for respectively.

These modules are enriched for following go terms: .

This gene is found to be for growth on cholesterol.

Mutant available?:

Product (LegacyBRC) Product (RefSeq)
Putative uncharacterized protein
Operon # Operon
PATRIC Locus Tag Enzyme Name Transcriptomics
Locus Tuberculist Genome View


Locus Tag KEGG Pathways


not assigned to any KEGG Pathway.
BioCyc Gene Page Cellular Overview Map
Link to STRING STRING Network


GI Number Protein ID Blast Conserved Domains
Description:Expression data from transcription factor over expression experiments. TFOE are matched to the ChIP-seq experiment done simultaneously. This dataset is described in Rustad et al. 2014, Genome Biology.
BioProject Accession GEO Series References Repository Sample Method Sample Type
PRJNA254351 GSM1426793 GSE59086 25232098 GEO Tiling Array RNA
PRJNA254351 GSM1426794 GSE59086 25232098 GEO Tiling Array RNA
PRJNA254351 GSM1426795 GSE59086 25232098 GEO Tiling Array RNA
Experiment UCSC Genome Browser
Rv2160a_B378 UCSC Browser Tracks
Quantitative Proteomics Data
t-test p-value Cholesterol/Glycerol Ratio

How essentiality calculations were done?

The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.

TRIP log2 fold abundance change

reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.

p-value Untreated: 0.00989217
p-value INH: 0.304719
Displaying 1 - 17 of 17
Condition Count Day Doublings Fitness U.I Plots
D0U 27 0 0.00 13.10 U
D3I 3 3 3.83 13.29 I
D3U 3 3 3.83 12.60 U
D5I 9 5 6.00 12.16 I
D5U 17 5 6.00 11.84 U
D7I 18 7 8.14 13.63 I
D7U 19 7 8.14 13.11 U
D14I 4 14 15.63 14.52 I
D14U 4 14 15.63 13.47 U
D17I 3 17 19.15 14.70 I
D17U 3 17 19.15 13.36 U
D21I 4 21 23.23 14.92 I
D21U 4 21 23.23 13.40 U
D24I 3 24 26.60 15.04 I
D24U 3 24 26.60 13.24 U
D28I 4 28 30.61 15.04 I
D28U 4 28 30.61 13.15 U